Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
Razvi, S
Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency. [electronic resource] - Clinical immunology (Orlando, Fla.) Dec 2001 - 284-8 p. digital
Publication Type: Journal Article
1521-6616
10.1006/clim.2001.5132 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antiviral Agents--therapeutic use
Child
Drug Contamination
Hepatitis C--drug therapy
Humans
Immunoglobulins, Intravenous--adverse effects
Immunologic Deficiency Syndromes--drug therapy
Interferon-alpha--therapeutic use
Middle Aged
Ribavirin--therapeutic use
Surveys and Questionnaires
Treatment Outcome
Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency. [electronic resource] - Clinical immunology (Orlando, Fla.) Dec 2001 - 284-8 p. digital
Publication Type: Journal Article
1521-6616
10.1006/clim.2001.5132 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antiviral Agents--therapeutic use
Child
Drug Contamination
Hepatitis C--drug therapy
Humans
Immunoglobulins, Intravenous--adverse effects
Immunologic Deficiency Syndromes--drug therapy
Interferon-alpha--therapeutic use
Middle Aged
Ribavirin--therapeutic use
Surveys and Questionnaires
Treatment Outcome